K. Papadopoulos
- Molecular Biology
- Oncology top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research
- Co-authors
- Anthony W. TolcherAmita PatnaikAlain C. MitaJohann S. de BonoDavid OlmosPamela BartelsAnne KeatingLionel D. Lewis
- Topics
- Lung Cancer Treatments and Mutations (14 papers)Cancer Immunotherapy and Biomarkers (10 papers)PI3K/AKT/mTOR signaling in cancer (9 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesSpainAustralia
In The Last Decade
K. Papadopoulos
55 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 598
- Oncology 540
- Immunology 299
- Pulmonary and Respiratory Medicine 215
- Cancer Research 131
Countries citing papers authored by K. Papadopoulos
This map shows the geographic impact of K. Papadopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Papadopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Papadopoulos more than expected).
Fields of papers citing papers by K. Papadopoulos
This network shows the impact of papers produced by K. Papadopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Papadopoulos. The network helps show where K. Papadopoulos may publish in the future.
Co-authorship network of co-authors of K. Papadopoulos
This figure shows the co-authorship network connecting the top 25 collaborators of K. Papadopoulos. A scholar is included among the top collaborators of K. Papadopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Papadopoulos. K. Papadopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 67 | |
| 11 | 1 | |
| 12 | 228 | |
| 13 | 67 | |
| 14 | 36 | |
| 15 | 22 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 208 | |
| 19 | Phase 1 clinical trials of NPI-2358 (a novel vascular disrupting agent) in patients with solid tumors and lymphomas | 1 |
| 20 | 30 |
About K. Papadopoulos
K. Papadopoulos is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). The work is most often cited by research in Oncology (540 citations), Immunology (299 citations) and Cancer Research (131 citations). K. Papadopoulos has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Anthony W. Tolcher, Amita Patnaik, Alain C. Mita, Johann S. de Bono, David Olmos, Pamela Bartels, Anne Keating, Lionel D. Lewis, Chris H. Takimoto and Christopher R. Garrett. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.